Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine Hydrochloride in Neurogenic Orthostatic Hypotension
NCT00555880Phase 4Completed
- Sponsor
- Takeda
- Start
- Sep 2004
- Primary completion
- Mar 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of midodrine in Neurogenic Orthostatic Hypotension (nOH), sponsored by Takeda. Started Sep 2004; status: completed.
02
Drugs
midodrine
03
Conditions
Neurogenic Orthostatic Hypotension (nOH)
Beyond the preview
Go deeper on NCT00555880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00555880.